- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03855319
Neurofeedback Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment (Neurofeedel)
February 26, 2019 updated by: Fabienne Marlats
SMR/Theta Neurofeedback Training Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment: A Pilot Study
This is a non-pharmacological pilot study showing the improvement of a SMR/theta neurofeedback training program on cognitive performance and EEG activity in Elderly with Mild Cognitive Impairment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Neurofeedback training (NF) as self-regulation method of brain activity, may be beneficial in elderly with mild cognitive impairment.
In this pilot study, the investigators studied whether a sensorimotor(SMR)/theta NF training could improve cognitive performance and brain electrical activity in a sample group of elderly patients with mild cognitive impairment.
Twenty participants performed an electroencephalography recording, a battery of neuropsychological tests before the neurofeedback training program (T0), following the neurofeedback training program (T1) and 1-month follow-up (T2).
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
61 years to 86 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Mild Cognitive Impairment
- education level of 9 years of studies minimum
- righthandedness
- subjective memory complaint confirmed by an informant
- a Mini Mental Status Examination score >20.
- preserve activity of daily living and absence of dementia.
Exclusion Criteria:
- elderly persons who were under guardianship
- resident in nursing facilities
- neurological disease, psychiatric disease
- and involved in another cogniitve intervention.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SMR neurofeedback training to MCI
A sensorimotor/theta neurofeedback training consisted of 20 individuals sessions, twice a week during 11 weeks maximum. For each subject, NF was planned and conducted by a neuropsychologist experienced in neurophysiology an neurofeedback. Each session lasted 1h10 minutes and was conducted as follows:
|
The intervention consisted to increase the synaptic strengths and sensitivity within this network.
Electroencephalography signals for SMR/theta training was recorded at channel Cz according to the international 10-20 system.
Theta rhythm was also recorded and, in this case, SMR was stimulated while theta waves were suppressed.A 32 channels system (EEGDigitrcak Biofeedback plus module, Inc Elmiko Medical) was used for the SMR/theta Neurofeedback training.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rey Auditory Verbal Learning test
Time Frame: Assessment at baseline, change from baseline to 11 weeks immediately after the NF training and 1 month follow-up
|
Assessment of verbal learning in episodic memory, evaluating the ability to encode, combine, store and long-term consolidation process.
|
Assessment at baseline, change from baseline to 11 weeks immediately after the NF training and 1 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative power for delta, theta, alpha, sensorimotor and lower beta frequency bands.
Time Frame: Assessment at baseline, change from baseline to 11 weeks immediately after the NF training and 1 month follow-up
|
Electroencephalography was recorded and EEG power spectrum was calculated using the fast Fourier transform.
The power spectral density was calculated to extract the relative power for each frequency band and estimated as a log-ratio.
|
Assessment at baseline, change from baseline to 11 weeks immediately after the NF training and 1 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: anne-Sophie AR Rigaud, Professor, Study Principal Investigator
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2016
Primary Completion (Actual)
December 15, 2018
Study Completion (Actual)
December 15, 2018
Study Registration Dates
First Submitted
February 25, 2019
First Submitted That Met QC Criteria
February 25, 2019
First Posted (Actual)
February 26, 2019
Study Record Updates
Last Update Posted (Actual)
February 28, 2019
Last Update Submitted That Met QC Criteria
February 26, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUS3EEGNF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Singapore General HospitalSingapore Health ServicesNot yet recruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment
-
Xuanwu Hospital, BeijingNot yet recruitingMild Cognitive Impairment (MCI)China
-
The Hong Kong Polytechnic UniversityJohns Hopkins University; The University of Hong Kong; University of ReadingNot yet recruitingMild Cognitive Impairment (MCI)Hong Kong
-
Universidad Complutense de MadridAB Biotics, SANot yet recruitingMild Cognitive Impairment (MCI)Spain
-
University of SheffieldNot yet recruitingMild Cognitive Impairment (MCI)United Kingdom
-
The Hong Kong Polytechnic UniversityRecruitingMild Cognitive Impairment (MCI)Hong Kong
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.TerminatedMild Cognitive Impairment (MCI)Taiwan
Clinical Trials on SMR neurofeedback training to MCI
-
Fabienne MarlatsCompletedMild Cognitive Impairment, So StatedFrance
-
University of HartfordCompleted
-
Chang Gung Memorial HospitalWithdrawnPost Operative Pain | Pain, Shoulder
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Leiden University Medical CenterCompletedElevated EEG Theta/Beta Ratio
-
Quietmind FoundationCompleted
-
Stanford UniversityCompleted
-
University of FloridaNational Institute on Aging (NIA)RecruitingCognitive Change | Aging | Neurocognitive Disorders, MildUnited States
-
Consorci Sanitari de TerrassaUniversity of Barcelona; Fundació La Marató de TV3; Associació Vallès Amics de...Unknown